At the molecular level, the explanation for the complex alteration profile of post-lanosterol biosynthesis is a potential (direct or indirect) EBP inhibition seen in Dhcr7T93M/T93M mouse neurons, glial cells, and human dermal fibroblasts from SLOS patients. Here, EBP is linked to Smith-Lemli-Opitz syndrome.